Trials / Completed
CompletedNCT01332383
Special Drug Use Investigation for AMERGE® Tablet (Long-term)
Special Drug Use Investigation for AMERGE Tablet (Long-term)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To investigate the long-term safety and efficacy of AMERGE (naratriptan hydrochloride) on Japanese patients with migraine headache in clinical setting
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Naratriptan |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2013-10-01
- Completion
- 2013-10-01
- First posted
- 2011-04-11
- Last updated
- 2015-08-13
Source: ClinicalTrials.gov record NCT01332383. Inclusion in this directory is not an endorsement.